Diabetologia 64 , 22042214 (2021)
Yet many people with excess weight dont take the shots due to cost, spotty insurance coverage and fear of needles. The oral formulation expands treatment options for patients who have avoided injectable GLP-1 therapy
Some agents, like semaglutide and dulaglutide, have also demonstrated cardiovascular and renal benefits in clinical trials
Diabetic retinopathy: This eye problem typically occurs in people with diabetes Possible increased risk of thyroid cancer: Seen in animal studies, it is not known if Wegovy can cause thyroid cancer in people
Known colloquially as Ozempic face, these changes include facial fat pad deflation, skin laxity, and an accelerated ageing appearance [2]
leves y temporales , especialmente al inicio del tratamiento: Nuseas leves Molestias digestivas Sensacin de plenitud Estreimiento o diarrea ocasional El seguimiento mdico mensual nos permite ajustar la dosis para minimizar cualquier molestia